2017
DOI: 10.1002/mc.22749
|View full text |Cite
|
Sign up to set email alerts
|

The role of the long non‐coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR‐93/RhoC pathway

Abstract: As one of the most frequently diagnosed cancers in women, the development and progression of epithelial ovarian carcinoma (EOC) remains an open area of research. The role of long non-coding RNAs (lncRNAs) in EOC is an emerging field of study. We found that LncRNA TDRG1 (human testis development-related gene 1) was highly expressed in EOC tissues than in normal ovarian tissues, and expression differed significantly with differentiation. LncRNA TDRG1 downregulation suppressed EOC cell proliferation, migration, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
24
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(26 citation statements)
references
References 26 publications
2
24
0
Order By: Relevance
“…Abnormal lncRNA levels can affect the cellular growth, migration, invasion, and cell cycle distribution of trophoblast cells to induce the occurrence and development of PE . There is evidence that TDRG1 is significantly overexpressed in epithelial ovarian cancer or endometrial cancer tissues, promoting cancer cell viability, invasion, and migration and inhibiting apoptosis . In this study, we found that TDRG1 was significantly down‐regulated in the placental tissues of PE patients, and we speculated that TDRG1 levels might be associated with PE development and progression.…”
Section: Discussionmentioning
confidence: 57%
“…Abnormal lncRNA levels can affect the cellular growth, migration, invasion, and cell cycle distribution of trophoblast cells to induce the occurrence and development of PE . There is evidence that TDRG1 is significantly overexpressed in epithelial ovarian cancer or endometrial cancer tissues, promoting cancer cell viability, invasion, and migration and inhibiting apoptosis . In this study, we found that TDRG1 was significantly down‐regulated in the placental tissues of PE patients, and we speculated that TDRG1 levels might be associated with PE development and progression.…”
Section: Discussionmentioning
confidence: 57%
“…It exclusively expressed in the testis in non-reproductive tissues, and plays a major role in regulating human spermatogenesis and sperm motility [8, 9]. With the in-depth research, TDRG1 was considered as a key regulator in reproductive organ related cancer such as testicular germ cell tumors (TGCT) [10, 32, 33], epithelial ovarian carcinoma [11] and endometrial carcinoma [12]. Down-regulated expression of TDRG1 reduced the biological activity of TGCT cells [10], and enhanced proliferation and migration of seminoma cells through modulation of the PI3 K/Akt/mTOR signaling pathway and mitochondria-mediated apoptotic pathway [32, 33].…”
Section: Discussionmentioning
confidence: 99%
“…Down-regulated expression of TDRG1 reduced the biological activity of TGCT cells [10], and enhanced proliferation and migration of seminoma cells through modulation of the PI3 K/Akt/mTOR signaling pathway and mitochondria-mediated apoptotic pathway [32, 33]. Furthermore, as a lncRNA, TDRG1 enhanced tumorigenicity by inhibiting the miR-93/RhoC pathway in epithelial ovarian carcinoma [11] and promoted endometrial carcinoma cell development and invasion by positively targeting VEGF-A in endometrial carcinoma [12]. However, there is no evidence that TDRG1 involved in regulation of the pathological process in CC.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations